Free Trial

Dimensional Fund Advisors LP Trims Position in Owens & Minor, Inc. (NYSE:OMI)

Owens & Minor logo with Medical background

Dimensional Fund Advisors LP decreased its holdings in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,702,248 shares of the company's stock after selling 98,203 shares during the quarter. Dimensional Fund Advisors LP owned approximately 6.10% of Owens & Minor worth $61,457,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Waldron Private Wealth LLC bought a new stake in shares of Owens & Minor during the fourth quarter valued at approximately $406,000. JPMorgan Chase & Co. increased its stake in shares of Owens & Minor by 68.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company's stock valued at $5,912,000 after buying an additional 152,999 shares during the period. Advisors Preferred LLC raised its position in shares of Owens & Minor by 173.9% during the fourth quarter. Advisors Preferred LLC now owns 84,305 shares of the company's stock worth $1,083,000 after acquiring an additional 53,529 shares during the last quarter. Barclays PLC increased its position in Owens & Minor by 354.8% in the third quarter. Barclays PLC now owns 133,702 shares of the company's stock worth $2,099,000 after purchasing an additional 104,305 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Owens & Minor by 6.0% during the 4th quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company's stock worth $8,142,000 after purchasing an additional 35,105 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Robert W. Baird boosted their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. UBS Group reduced their price target on Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Citigroup dropped their price objective on Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Finally, JPMorgan Chase & Co. decreased their target price on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a research report on Monday, March 10th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $12.50.

View Our Latest Stock Analysis on Owens & Minor

Owens & Minor Stock Performance

Owens & Minor stock traded up $0.07 during mid-day trading on Wednesday, hitting $7.78. 77,121 shares of the company's stock traded hands, compared to its average volume of 1,110,313. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a 50 day simple moving average of $8.27 and a two-hundred day simple moving average of $10.92. Owens & Minor, Inc. has a fifty-two week low of $6.07 and a fifty-two week high of $21.02. The stock has a market cap of $601.04 million, a price-to-earnings ratio of -11.97, a P/E/G ratio of 0.20 and a beta of 1.38.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company's quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.69 EPS. On average, research analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor declared that its Board of Directors has authorized a share buyback program on Friday, February 28th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the company to purchase up to 13.6% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board believes its shares are undervalued.

Insider Activity at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L bought 354,901 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were bought at an average price of $9.19 per share, for a total transaction of $3,261,540.19. Following the completion of the acquisition, the insider now directly owns 9,824,599 shares of the company's stock, valued at $90,288,064.81. This trade represents a 3.75 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders purchased a total of 2,718,412 shares of company stock valued at $24,495,308 in the last quarter. Insiders own 3.69% of the company's stock.

About Owens & Minor

(Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

See Also

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines